CAT No: CP26958
CAS No:28782-78-7
Synonyms/Alias:28782-78-7; BOC-Ala-Gly; BOC-ALA-GLY-OH; (S)-2-(2-((tert-Butoxycarbonyl)amino)propanamido)acetic acid; n-(tert-butoxycarbonyl)-l-alanylglycine; AC1L4UAI; N-[N-[(1,1-Dimethylethoxy)carbonyl]-L-alanyl]glycine; AC1Q5XN8; SCHEMBL8536884; MolPort-006-125-650; ZINC2556536; AR-1K0239; AKOS015914167; AJ-39922; AK-48102; N-(N-tert-butoxycarbonyl-alanyl)-glycine; KB-300021; ST2402764; 2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]acetic acid; Glycine, N-[(1,1-dimethylethoxy)carbonyl]-L-alanyl-; (tert-butoxycarbonyl)-L-alanylglycine; MFCD00235759; Boc-Ala-Gly-OH, AldrichCPR; HY-W019684; DA-51279; DS-14559; CS-0030797; NS00047500; (S)-2-(2-(tert-butoxycarbonylamino)propanamido)acetic acid; [(2S)-2-[(tert-Butoxycarbonyl)amino]propanamido]acetic acid (Boc-L-Ala-Gly-OH)
1. Cationic cell-penetrating peptides are potent furin inhibitors
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.